Cost-Utility Analysis of Atazanavir/Ritonavir 200/100 Mg Versus Atazanavir/Ritonavir 300/100 Mg in Thai Adults with Virologic Suppression
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.148
https://www.valueinhealthjournal.com/article/S1098-3015(16)30728-8/fulltext
Title :
Cost-Utility Analysis of Atazanavir/Ritonavir 200/100 Mg Versus Atazanavir/Ritonavir 300/100 Mg in Thai Adults with Virologic Suppression
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30728-8&doi=10.1016/j.jval.2016.08.148
First page :
A912
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2868